Radiation Planning Study for High Grade Brain Tumors

The purpose of this research study is to see if a higher strength MRI procedure provides better images to use in planning radiation treatments for patients with brain tumors in the future.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

High Grade Glioma Glioma Neoplasms Neoplasms by Histologic Type Neoplasms, Germ Cell and Embryonal Neoplasms, Glandular and Epithelial Neoplasms, Nerve Tissue Neoplasms, Neuroepithelial Neuroectodermal Tumors

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Cincinnati

Cincinnati, Ohio, 45219, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Histologically confirmed, newly diagnosed Grade III-IV glioma
Planning to undergo radiation therapy

Exclusion criteria

Grade I or II glioma
Patients unable to undergo MRI imaging

Treatment and study plan

3T MRI

Other

3T MRI in addition to standard 1.5T MRI for treatment planning

Primary outcomes

Treatment volume

Time frame: 1 year average

To assess the difference in treatment volume for radiation planning in gliomas as calculated using 1.5T versus 3T magnets

Sponsors and collaborators

Lead sponsor

University of Cincinnati

Other

Registry information

Official study title

3T Versus 1.5T MR Approaches in Target Definition for Malignant Gliomas: Is There a Significant Difference in Tumor Extent and Radiation Treatment Volume?

Important dates

Study start: 2010
Primary completion: 2013
Study completion: 2013
First posted: Aug 30, 2010
Registry last updated: Aug 22, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed